Patients with resectable NSCLC undergoing neoadjuvant chemoimmunotherapy may have worse OS if they have low preoperative hemoglobin levels.
This new study examined postoperative survival among discharged patients following treatment of non–small cell lung cancer (NSCLC) via surgical resection using the National Cancer Database. The ...
This analysis looked at 6 different preoperative measures of systemic inflammation and outcomes in more than 5000 patients who underwent lung resection for primary NSCLC. The investigators concluded ...
LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...
Visceral pleural invasion of non–small cell lung cancer (NSCLC) was investigated in this analysis for its potential to predispose patients to worse survival outcomes and greater chances of disease ...
Assessment of survival benefit with immunotherapy in combination with adjuvant chemoradiation in pathologic stage II-IIIB non-small cell lung cancer. Adjuvant icotinib of 12 months versus observation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results